Targeting FMRP: A new window for cancer immunotherapy

Saved in:
Bibliographic Details
Main Authors: Yaguang Zhang, Tong Wu, Junhong Han
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:MedComm
Online Access:https://doi.org/10.1002/mco2.233
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589929847193600
author Yaguang Zhang
Tong Wu
Junhong Han
author_facet Yaguang Zhang
Tong Wu
Junhong Han
author_sort Yaguang Zhang
collection DOAJ
format Article
id doaj-art-a2c478b5c70c4368b683358b2dfc6450
institution Kabale University
issn 2688-2663
language English
publishDate 2023-04-01
publisher Wiley
record_format Article
series MedComm
spelling doaj-art-a2c478b5c70c4368b683358b2dfc64502025-01-24T05:36:29ZengWileyMedComm2688-26632023-04-0142n/an/a10.1002/mco2.233Targeting FMRP: A new window for cancer immunotherapyYaguang Zhang0Tong Wu1Junhong Han2State Key Laboratory of Biotherapy and Cancer Center, and Frontiers Science Center for Disease‐Related Molecular Network West China Hospital Sichuan University Chengdu P. R. ChinaState Key Laboratory of Biotherapy and Cancer Center, and Frontiers Science Center for Disease‐Related Molecular Network West China Hospital Sichuan University Chengdu P. R. ChinaState Key Laboratory of Biotherapy and Cancer Center, and Frontiers Science Center for Disease‐Related Molecular Network West China Hospital Sichuan University Chengdu P. R. Chinahttps://doi.org/10.1002/mco2.233
spellingShingle Yaguang Zhang
Tong Wu
Junhong Han
Targeting FMRP: A new window for cancer immunotherapy
MedComm
title Targeting FMRP: A new window for cancer immunotherapy
title_full Targeting FMRP: A new window for cancer immunotherapy
title_fullStr Targeting FMRP: A new window for cancer immunotherapy
title_full_unstemmed Targeting FMRP: A new window for cancer immunotherapy
title_short Targeting FMRP: A new window for cancer immunotherapy
title_sort targeting fmrp a new window for cancer immunotherapy
url https://doi.org/10.1002/mco2.233
work_keys_str_mv AT yaguangzhang targetingfmrpanewwindowforcancerimmunotherapy
AT tongwu targetingfmrpanewwindowforcancerimmunotherapy
AT junhonghan targetingfmrpanewwindowforcancerimmunotherapy